Loading clinical trials...

Genomic Predictors of Papillary Microcarcinoma Disease Progression | Clinical Trials | Clareo Health

RECRUITINGNCT02363595

Genomic Predictors of Papillary Microcarcinoma Disease Progression

The study is being done to answer the following question: What are the specific clinical and molecular features that will help us predict which small thyroid cancers are likely to grow and be problema...

Lead sponsor: Memorial Sloan Kettering Cancer Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Robert Tuttle, MD

CONTACT

646-888-2716

Michael Berger, PhD

CONTACT

646-888-3386

Related studies

Active Not Recruiting

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

NCT04624477 · Papillary Thyroid Cancer, Papillary Thyroid Carcinoma, and more

UNKNOWNNA

Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma

NCT04129281 · Papillary Microcarcinoma of the Thyroid

COMPLETED

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

NCT01392222 · Thyroid Cancer, Papillary Microcarcinoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 12, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment750

Start dateDec 2014

Last updatedMar 12, 2026

Condition

Papillary Microcarcinoma

Locations shown

Memorial Sloan Kettering Cancer Center

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions